<?xml version="1.0" encoding="UTF-8"?>
<p id="p0075">Scientific collaborations have revealed that cytopathic effects and poor prognosis are associated with increased release of cytokines such as interleukin-6 and discovered that the angiotensin converting enzyme 2 receptor (ACE2) serves as the infective portal of entry (
 <xref rid="b0035" ref-type="bibr">Cai, 2020</xref>, 
 <xref rid="b0255" ref-type="bibr">Letko and Munster, 2020</xref>, 
 <xref rid="b0470" ref-type="bibr">Zhu et al., 2020</xref>). The host virus uses its CoV S protein receptor binding motif to bind ACE2 in the target cell (
 <xref rid="b0295" ref-type="bibr">Millet and Whittaker, 2015</xref>). Injury is thought to occur by the downregulation of ACE2 in alveolar cells, which normally provide a protective function against lung injury (
 <xref rid="b0445" ref-type="bibr">Xu et al., 2020</xref>). Downregulation of ACE2 leads to downstream effects, including upregulating type 1A ACE2 receptors, and results in increased pulmonary vascular permeability (
 <xref rid="b0215" ref-type="bibr">Imai et al., 2005</xref>).
</p>
